Direct Epidemio-Statistics — Expert office in epidemiostatistics and risk
We help SMEs and innovative companies leverage precise data, model and score risks, anticipate adverse events, and create value-driven services.
Nov 26, 2025Rail Live 2025, Madrid, ES
Conversations and exchanges on railway infrastructure.
Nov 20, 2025OVHSummit, Paris, FR
Back again this year.
Nov 19, 2025Salon des Maires et des Collectivités Locales, Paris, FR
Conversations, exchanges, and real-world feedback.
Nov 18, 2025SOLUTRANS 2025, Lyon, FR
Conversations, exchanges, and real-world feedback in Lyon.
Nov 5, 2025RNTP 2025, Orléans, FR
Exchanges with public transport stakeholders.
Nov 4, 2025Journées de la filière auto (PFA — Filière Automobile & Mobilités)
Meetings with PFA, automotive & mobility sector.
Sep 11, 2025MOUV'INDUSTRIE, Circuit des 24h du Mans, FR
Exchanges with partners.
Jun 16, 2025UITP 2025, Hamburg, DE
Discussions about SAMRoute.
Apr 2, 2025SITL 2025, Paris, FR
Attendance, networking and discussions about SAMRoute.
Feb 6, 2025FLOTAUTO, Paris, FR
Attendance, networking and discussions about SAMRoute.
Jan 22, 2025ATEC ITS, Paris, FR
Attendance, networking and discussions about SAMRoute.
Nov 28, 2024OVHSummit, Paris, FR
Present at the annual event of our technical sponsor (thank you!).
Nov 20, 2024Mayors and Local Authorities Fair, Paris, FR
Discussions about the SAMRoute software, networking.
Nov 6, 2024Smart City Expo, Barcelona, ES
Discussions about the SAMRoute software, networking.
Oct 16, 2024Paris Motor Show, Paris, FR
Discussions about the SAMRoute software, networking.
Oct 1–4, 2024Livestock Summit, Clermont-Ferrand, FR
On-site presence to discuss agrivoltaics.
Nov 12–18, 2023AGRITECHNICA, trade fair for agricultural machinery, DE
Immersion to understand risks and solutions.
Nov 10, 2023SRA Technical Day (France Assureurs), Paris, FR
Presentation of the global road risk scoring and Q&A.
Our expertise
What are Direct Epidemio-Statistics' areas of expertise?
Statistical epidemiology
A broad, comprehensive spectrum of statistical methods to:
- characterize, model, and compare your study populations
- improve survival, quality of life, or complication counts
- reduce the number of serious adverse events (SAEs)
- conduct health surveillance.
Excerpts / client case
Quantitative risk
Methods and solutions at every stage of your at-risk case management process, notably to:
- better understand the pathogenesis of your adverse events
- summarize and compare characteristics of studied populations
- improve yields or techno-economic efficiency
- proactively monitor your at-risk cases...
Excerpts / client case
Market access marketing
Argumentation intelligence and techno-scientific marketing to:
- present your studies — methodology, tables, charts
- defend your market access, notably during expert reviews
- produce marketing collateral showcasing your results or products.
Our expert missions
Feasibility studyProtocol designCohort follow-upAnalysis and synthesisMarket access marketingExcerpts / client case
Your benefits
What can Direct Epidemio-Statistics bring you?
Clarified pathogeneses
Expert help to detect precursor or causal factors that contribute to the emergence, development, or maintenance of adverse events (SAEs).
Ambition, results, and performance
To accelerate change and save time, cut direct and ancillary costs, or secure performance with more reliable processes.
More simplicity and efficiency
To reduce overall process complexity, improve compliance with rules or standards, gain autonomy and responsiveness, and enhance operational practicality and comfort.
A lasting, planned, adaptable partnership
Pre-assess techno-economic feasibility; help you anticipate, plan ahead, and broaden perspective; while staying responsive and available to solve punctual challenges.
Advisory, commitment, and trust
A partner who supports you, advises you, respects your approach, and keeps their expertise at your disposal.
The + of Direct Epidemio-Statistics
What makes us specific?
First reason: our advisory expertise
Second reason: our French CIR accreditation (R&D tax credit) granted by the Ministry of Higher Education and Research, which:
- reduces our billed R&D cost by 30% via tax credit;
- is an indicator of our experience, expertise, and professionalism;
- covers the period 2022–2027.
Third reason: our mindset, characterized by:
- innovative choices, no taboos, detached from the status quo;
- punctuality and goal achievement, building reliability and trust;
- neutrality when surveying possible options;
- availability and accessibility.